Skip to content
Toggle main navigation
Immunize Oregon logo
Immunize Oregon logo
  • Welcome
    • Immunize Oregon
  • Vaxx Clinic
  • Events
  • Groups
  • News
  • Opportunities
  • Lobby
MoreOpen dropdown to see remaining menu items
    Log in
    Request to join
    Select an available language
    EN
    Contact
    Immunize Oregon
    PO BOX 4391, Portland, Oregon 97208

    United States

    [email protected]
    Links
    Immunize Oregon Website
    Cookies
    Withdraw cookie consent
    Community engagement platform by Hivebrite.

    News

    All
    3-D printing
    Abdul Latif Jameel Poverty Action Lab (J-PAL)
    Administration
    Aeronautical and astronautical engineering
    Africa
    Algorithms
    Alumni/ae
    Alzheimer's
    Anesthesia
    Anthropology
    Antibiotics
    Artificial intelligence
    Asia
    Autism
    Awards, honors and fellowships
    See all

    Highlighted News

    Results (2170)

    Newest
    A cancer therapy put severe rheumatoid arthritis into remission

    A cancer therapy put severe rheumatoid arthritis into remission

    CAR T-cell therapy dramatically reduced disease activity in six people with severe rheumatoid arthritis that had resisted other treatments, with three achieving medication-free remission. The treatment may work by clearing out harmful immune cells and effectively rebooting part of the immune system, although much larger studies are still needed.
    August 30, 2026
    Shingles vaccine linked to 24% lower dementia risk

    Shingles vaccine linked to 24% lower dementia risk

    Older adults who received the Shingrix shingles vaccine were 24% less likely to be diagnosed with dementia over four years in a study of more than 500,000 people. Researchers estimate the difference could amount to roughly one dementia case prevented for every 17 people vaccinated.
    August 25, 2026
    Bird flu is spreading. Your backyard feeder could make it worse

    Bird flu is spreading. Your backyard feeder could make it worse

    Backyard bird feeders could become unexpected hotspots for H5N1 as Australia’s bird flu outbreak spreads, bringing species together in ways that rarely occur naturally. Experts say stopping feeding is safest, while smaller amounts of food, no hand-feeding, and careful cleaning can reduce the danger.
    August 24, 2026
    AI may know how you’ll respond to a vaccine before you get it

    AI may know how you’ll respond to a vaccine before you get it

    AI may be able to predict how strongly someone will respond to a vaccine before they receive it. By analyzing antibody patterns in more than 4,000 people, researchers found signs of “immune readiness” that helped distinguish strong responders from weak ones. Surprisingly, even some healthy people responded poorly, while some immunosuppressed people mounted strong responses.
    August 21, 2026
    Cancer-fighting chewing gum cuts HPV levels by up to 93%

    Cancer-fighting chewing gum cuts HPV levels by up to 93%

    A specially engineered chewing gum reduced HPV by up to 93% and nearly eliminated two bacteria linked to head and neck cancer. The treatment preserved beneficial mouth bacteria, raising hopes for a safer and more affordable therapy.
    August 4, 2026
    New molecular map reveals how the flu virus hijacks human cells

    New molecular map reveals how the flu virus hijacks human cells

    Scientists uncovered how influenza A commandeers human cells, including a surprising strategy that dissolves tiny structures in the nucleus and releases proteins the virus may use to reproduce. The detailed molecular map could reveal new drug targets and help researchers study dangerous flu strains such as H5N1.
    July 21, 2026
    This food compound may help vaccines work better in older adults

    This food compound may help vaccines work better in older adults

    A naturally occurring compound found in foods such as wheat germ, mushrooms, and aged cheese may help older adults build stronger protection after vaccination. In a small pilot trial, researchers gave spermidine supplements to adults over 65 following their third COVID-19 vaccine dose. The biggest improvements appeared among people whose immune systems initially responded poorly, with higher antib
    July 21, 2026
    A hidden immune backup system could supercharge mRNA cancer vaccines

    A hidden immune backup system could supercharge mRNA cancer vaccines

    Researchers found that mRNA cancer vaccines can recruit an unexpected immune cell to launch powerful tumor-fighting responses, overturning a long-held assumption about how the vaccines work. The discovery could lead to more effective cancer vaccines and help scientists tailor treatments for better patient outcomes.
    July 9, 2026
    Johns Hopkins scientists develop nose spray DNA vaccine for tuberculosis

    Johns Hopkins scientists develop nose spray DNA vaccine for tuberculosis

    A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can hide from antibiotics. In animal studies, it helped clear infections faster, reduced lung inflammation, and prevented relapse after treatment. The vaccine also enhanced the performance of drugs used against drug-resistant TB.
    July 4, 2026
    One tiny mutation may explain how bat viruses become human threats

    One tiny mutation may explain how bat viruses become human threats

    Scientists found that one tiny genetic change can completely alter how a coronavirus behaves in different species. Comparing SARS-CoV-2 with a closely related bat-only virus, they showed that a single amino-acid difference affects whether the immune system fights back or gets suppressed. This may help explain how some animal viruses make the leap to humans and become far more dangerous.
    June 24, 2026
    Scientists finally solved how H5N1 bird flu hid in dairy cows

    Scientists finally solved how H5N1 bird flu hid in dairy cows

    Researchers uncovered why H5N1 bird flu attacks cows’ udders instead of their lungs: the virus’s preferred receptors are concentrated in mammary tissue. The breakthrough could help scientists predict future bird flu jumps and spot unusual infections before they spread widely.
    June 23, 2026
    Harriet having it all

    Harriet having it all

    In winter 1997, at age 60, when many researchers might be looking forward to retirement, Harriet Latham Robinson SM ’61, PhD ’65 was pursuing a faculty position as the chief of microbiology and immunology at the Yerkes National Primate Research Center at Emory University in Atlanta, Georgia. She got the job. There, she would also co-found GeoVax, a biotechnology company, based on her preclinical r
    June 12, 2026
    The long history of vaccine hesitancy

    The long history of vaccine hesitancy

    Debates about vaccines are a recurring feature of contemporary politics. It turns out they actually date back more than 200 years, since the development of the first smallpox vaccine. MIT Professor Thomas Levenson, one of the country’s leading science writers, explores this important history in a new book about the contours of anti-vaccination thought. Levenson identifies different types of argume
    June 12, 2026
    AI-designed universal coronavirus vaccine passes first human trial

    AI-designed universal coronavirus vaccine passes first human trial

    Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to be safe and well tolerated. The vaccine generated immune responses against multiple coronaviruses, including SARS-CoV-2, SARS, and related bat viruses with pandemic potential. By targeting features shared across an entire virus family, it aims to provide protection even as v
    June 5, 2026
    A new vaccine adjuvant could make it easier to eradicate polio

    A new vaccine adjuvant could make it easier to eradicate polio

    In the United States, children routinely receive an injectable form of the polio vaccine. This vaccine is very effective at preventing illness, but it doesn’t block transmission of the polio virus as well as the oral polio vaccine does.Poliovirus is usually transmitted through contaminated food or water, so the GI tract is where the body is first exposed. Because the oral vaccine induces a mucosal
    June 3, 2026
    Scientists discover a two-stage aging process that may cause cancer and arthritis

    Scientists discover a two-stage aging process that may cause cancer and arthritis

    A new theory suggests many age-related diseases may actually start decades before symptoms appear. Researchers say early-life damage — from infections, injuries, or genetic mutations — can remain hidden until aging weakens the body’s ability to keep it under control. This could explain why conditions like cancer, osteoarthritis, and shingles suddenly emerge later in life.
    May 22, 2026
    A new approach to cancer vaccination yields more powerful T cells

    A new approach to cancer vaccination yields more powerful T cells

    MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines — an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.Most vaccines generate both antibodies and T cells that can target the vaccine antigen by activating antigen-presenting cells, such as dendritic cells. In this study, the researchers boosted the
    May 13, 2026
    Past Flu Season Severity Assessments

    Past Flu Season Severity Assessments

    CDC researchers used key flu indicator data to develop intensity thresholds (ITs) to classify the severity of flu seasons.
    May 1, 2026
    Scientists finally crack mystery of rare COVID vaccine blood clots

    Scientists finally crack mystery of rare COVID vaccine blood clots

    Researchers have uncovered why a rare blood clotting disorder can occur after certain COVID-19 vaccines or adenovirus infections. The immune system can mistakenly target a normal blood protein (PF4) after confusing it with a viral protein. This triggers clotting in extremely rare cases. The breakthrough means vaccines can now be redesigned to avoid this reaction while staying effective.
    April 11, 2026
    This common vaccine cuts heart risk nearly in half in new study

    This common vaccine cuts heart risk nearly in half in new study

    A shingles vaccine might double as a powerful heart protector. In people already at high risk, it cut major cardiac events by 46% and deaths by an impressive 66% within a year. Scientists think preventing shingles may also stop clot-related complications that can lead to heart attacks and strokes. The effect is so strong, it rivals the benefits of quitting smoking.
    March 20, 2026